---
title: "Daiichi Sankyo and Waiv partner for ADC biomarkers"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285532705.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-05-07T09:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285532705.md)
  - [en](https://longbridge.com/en/news/285532705.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285532705.md)
---

# Daiichi Sankyo and Waiv partner for ADC biomarkers

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [4568.JP](https://longbridge.com/en/quote/4568.JP.md)
- [DSNKY.US](https://longbridge.com/en/quote/DSNKY.US.md)

## Related News & Research

- [<![CDATA[FDA Expands Enhertu in Early HER2-Positive Breast Cancer]]>](https://longbridge.com/en/news/286780814.md)
- [AZN :FDA Approves ENHERTU For HER2-Positive Early Breast Cancer In Neoadjuvant And Adjuvant Settings](https://longbridge.com/en/news/286677080.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)
- [Top Brass Makes Bold Insider Move at Agree Realty](https://longbridge.com/en/news/286851346.md)
- [Sutro Biopharma: Buy Rating on Strong ADC Execution, Cash Runway Into 2028, and Multiple 2026 Catalysts](https://longbridge.com/en/news/286599325.md)